Previous Close | 1.5300 |
Open | 1.5475 |
Bid | 1.3300 x 800 |
Ask | 2.8400 x 1000 |
Day's Range | 1.4800 - 1.5475 |
52 Week Range | 1.2400 - 12.6000 |
Volume | |
Avg. Volume | 48,383 |
Market Cap | 2.797M |
Beta (5Y Monthly) | 2.75 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3150 |
Earnings Date | Mar 27, 2023 - Mar 31, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.00 |
EMERYVILLE, Calif. & KIRKWOOD, Mo., March 14, 2023--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces a partnership with Eyeganics to sell OTC Organic Tears (0.2% organic glycerin) on Avenova.com and through Avenova’s physician-dispensed channel. Organic Tears has no additives or artificial chemicals and is the only lubricant eye drop certified by the USDA as 100% organic and preservative-free.
EMERYVILLE, Calif., March 07, 2023--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of OTC Avenova Eye Health Support oral supplement featuring a combination of MaquiBright®, a nutrient-rich, antioxidant-dense extract of the superfruit maqui berry, and high quality, natural triglyceride omega-3 oils to comfort dry eyes and support overall eye health.
EMERYVILLE, Calif., February 06, 2023--NovaBay announces DERMAdoctor's Eczema Treatment to be featured on Two QVC® Shows on February 7